Squarepoint Ops LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$340,160

-$241,836 QoQ

Shares Held

25,576

-59.1% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#83

of 158 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,789,234 across 255 Biotechnology names. FDMT ranks #173 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$340,160	25,576	-59.1%	Shares	Defined	2026-08-14
2026-03-31	$581,996	62,513	-12.8%	Shares	Defined	2026-05-15
2025-12-31	$537,907	71,721	+53.1%	Shares	Defined	2026-02-13
2025-09-30	$407,013	46,837	-11.4%	Shares	Defined	2025-11-14
2025-06-30	$196,181	52,879	+5.1%	Shares	Defined	2025-08-27
2024-09-30	$543,959	50,320	-54.3%	Shares	Defined	2024-11-14
2024-06-30	$2,309,760	110,041	+652.7%	Shares	Defined	2024-08-14
2024-03-31	$465,761	14,619	-69.4%	Shares	Defined	2024-05-15
2023-09-30	$607,844	47,749	+225.0%	Shares	Defined	2023-11-14
2023-06-30	$265,502	14,693	-76.1%	Shares	Defined	2023-08-14
2023-03-31	$1,054,744	61,358	-1.2%	Shares	Defined	2023-05-15
2022-12-31	$1,379,818	62,126	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.